Skip to Main Content

Try STAT+ TODAY

Links

Most Read

STAT Staff

Treating Depression: A new era of promising drugs

Don't Miss STAT Staff

Introducing the 2023 STATUS List, the definitive accounting of leaders in the life sciences

Health Felice J. Freyer — Boston Globe

Massachusetts detects troubling new strain of gonorrhea

STAT

Targeting cancer: the new frontier of immunotherapy and precision oncology

A STAT Investigation Nicholas Florko

DEATH SENTENCE: An 8-part investigation into prisons’ refusal to treat hepatitis C

Health Rebecca Ostriker, Deirdre Fernandes, Liz Kowalczyk, Jonathan Saltzman, and Patricia Wen — Boston Globe

A celebrated surgeon, a trail of secrets, and death

STAT

The need for speed and safety: A primer on the FDA’s drug approval pathways

Health Kay Lazar — Boston Globe

A puzzling phenomenon: Patients report a rebound of Covid-19 symptoms after taking the antiviral Paxlovid

All Coverage

The Readout Damian Garde

Should the feds investigate Aduhelm? Plus: biotech’s biggest binaries & regenerating heart tissue

Morning Rounds Shraddha Chakradhar

LA County urges masking for vaccinated people, declines in cancer screening, & new funding for gender equity

The Readout Damian Garde

Docs disagree with FDA on Aduhelm, Swiss giants pinch pennies, & one SPAC makes it rain

Morning Rounds Kate Sheridan

Covid-19 vaccine lessons, doctors’ attitudes on Aduhelm, & growing pains with type 2 diabetes care

The Readout Damian Garde

How Biogen got Aduhelm approved, Sanofi’s future in mRNA, & Celgene’s endless saga

Morning Rounds Kate Sheridan

Biogen’s FDA back-channels, the healthiest county in America, & inequalities in prostate care

The Readout Meghana Keshavan

Aduhelm’s impact on Medicare, a new CRISPR therapy, & a Warp Speed retirement

Morning Rounds Theresa Gaffney

Aduhelm’s potential impact on Medicare, vaccination while pregnant, & the pandemic’s toll on public health workers

The Readout Damian Garde

Lilly’s FDA gamble, Biogen’s would-be windfall, & GSK’s existential malaise

Morning Rounds Shraddha Chakradhar

Africa battling third Covid wave, CDC panel endorses dengue vaccine, & scientists return to pre-pandemic projects

The Readout Damian Garde

TIGIT’s latest twist, Biogen breaks its silence, & the future of GSK

Morning Rounds Shraddha Chakradhar

Association between mRNA vaccines and heart side effects, the stopping limit for Aduhelm, & lawmakers slam FDA for inaction on vaping

The Readout Damian Garde

Inside the FDA’s Aduhelm decision, GSK’s pitch for the future, & a biopharma gadfly joins the industry

Morning Rounds Shraddha Chakradhar

Experts to discuss rare heart side effects in vaccinated teens, White House concedes missing July 4 vaccine goal, & a call to end the global gag rule

The Readout Damian Garde

Aduhelm’s other profiteers, the latest SPAC merger, & BIO’s CEO on FDA rumors

Morning Rounds Shraddha Chakradhar

Hot spots for colorectal cancer in the U.S., Proove Biosciences’ ex-CEO indicted for fraud, & linking birthdays with Covid risk